本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Mereo Biopharma Group Plc

1.95
+0.12006.56%
盤後1.92-0.0300-1.54%17:38 EDT
成交量:115.15萬
成交額:219.41萬
市值:3.10億
市盈率:-6.67
高:1.98
開:1.84
低:1.78
收:1.83
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
更多
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
2025/03/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/26

重要事件披露

Form 8-K - Current report
2025/01/23

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/03

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities

如果下載按鈕點擊無跳轉,請點擊右上角菜單選擇 “在瀏覽器打開”